Pressing Pause on Psychedelic Cash

Analysing the Challenges in Psychedelic Drug Development Through Investment Trends

Adrienne Rivlin

Read more

Related Insights

Published Articles

Life Sciences & Pharma

The Growth of Radiotherapeutics: Addressing Supply Chain Complexity

May 21, 2025

Life Sciences & Pharma

Global Manufacturing Footprint Rationalization for a Leading Biopharmaceutical Company

March 31, 2025

A leading biopharmaceutical company engaged L.E.K. Consulting to optimize its global manufacturing network. The client sought to reduce costs while…

Biotech and Pharmaceuticals

Supporting an Emerging Biopharma To Build Out AI With Confidence

October 22, 2024

Executive Insights

Life Sciences & Pharma

Preparing for Innovation: A Maturity Framework for Artificial Intelligence in Life…

August 2, 2024

Published Articles

Data & Analytics

Use Data and Analytics to Create Your Strategy, Not Just Drive It: Why Critical Decisions…

July 23, 2024

Life Sciences & Pharma

A New Generation of Drug Therapies Requires New Business Strategies

July 10, 2024